Eloxx Pharmaceuticals Inc (ELOX) earnings · $314 cap
Eloxx Pharmaceuticals Inc (ELOX) is a biotechnology company listed on US.
This ELOX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ELOX revenue for 2025-12-31 was $0. Net income was -$6.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ELOX currently screens at market cap $314.
When the next ELOX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ELOX research stays on the stock page; the tape stays on the quote page.
Not investment advice.